James Ford
Publication Details
-
Characterization of the pathogenic mechanism of a novel BRCA2 variant in a Chinese family.
Fam Cancer. 2008; (2): 125-33
Germline mutations of BRCA1 and BRCA2 account for the majority of hereditary breast cancers, many of which are classified as variants of unknown significance (VUS). We report the identification of a novel BRCA2 variant (c.7806-9T > G) in a Chinese family with multiple breast cancers and document it as a pathogenic mutation.
Help
Trial Administration